End-payor, direct purchaser classes should be certified in Actos antitrust case, US magistrate judge recommends
MLex Summary: End-payor and direct purchaser plaintiffs bringing US antitrust claims against Takeda over its diabetes drug Actos should be granted class certification, a federal magistrate judge recommended. If approved, the...To view the full article, register now.
Already a subscriber? Click here to view full article